PCSK1 and metabolic dysfunction-associated steatotic liver disease: In summary, the inhibition of necroptosis by Nec-1 and GSK′872 could reduce the inflammatory response after IRI in NAFLD, which might be another mechanism protecting the fatty liver from IRI.